These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

607 related items for PubMed ID: 28381136

  • 1. Expression of Glut-1 in Normal Endometrium and Endometrial Lesions: Analysis of 336 Cases.
    Němejcová K, Rosmusová J, Bártů M, Důra M, Tichá I, Dundr P.
    Int J Surg Pathol; 2017 Aug; 25(5):389-396. PubMed ID: 28381136
    [Abstract] [Full Text] [Related]

  • 2. GLUT-1 Expression in Proliferative Endometrium, Endometrial Hyperplasia, Endometrial Adenocarcinoma and the Relationship Between GLUT-1 Expression and Prognostic Parameters in Endometrial Adenocarcinoma.
    Canpolat T, Ersöz C, Uğuz A, Vardar MA, Altintaş A.
    Turk Patoloji Derg; 2016 Aug; 32(3):141-7. PubMed ID: 27562387
    [Abstract] [Full Text] [Related]

  • 3. [Expression of beta-catenin, Glut-1, PTEN proteins in uterine endometrioid adenocarcinoma and its precursor lesions].
    Xiong Y, Xiong YY, Zhou YF.
    Zhonghua Bing Li Xue Za Zhi; 2009 Sep; 38(9):594-9. PubMed ID: 20079187
    [Abstract] [Full Text] [Related]

  • 4. The oncofetal protein IMP3: a novel biomarker for endometrial serous carcinoma.
    Zheng W, Yi X, Fadare O, Liang SX, Martel M, Schwartz PE, Jiang Z.
    Am J Surg Pathol; 2008 Feb; 32(2):304-15. PubMed ID: 18223334
    [Abstract] [Full Text] [Related]

  • 5. Expression and significance of beta-catenin, Glut-1 and PTEN in proliferative endometrium, endometrial intraepithelial neoplasia and endometrioid adenocarcinoma.
    Xiong Y, Xiong YY, Zhou YF.
    Eur J Gynaecol Oncol; 2010 Feb; 31(2):160-4. PubMed ID: 20527231
    [Abstract] [Full Text] [Related]

  • 6. Hyperplasia and carcinoma in secretory endometrium: a diagnostic challenge.
    Truskinovsky AM, Lifschitz-Mercer B, Czernobilsky B.
    Int J Gynecol Pathol; 2014 Mar; 33(2):107-13. PubMed ID: 24487463
    [Abstract] [Full Text] [Related]

  • 7. GLUT-1 is preferentially expressed in atypical endometrial hyperplasia and endometrial adenocarcinoma.
    Ashton-Sager A, Paulino AF, Afify AM.
    Appl Immunohistochem Mol Morphol; 2006 Jun; 14(2):187-92. PubMed ID: 16785788
    [Abstract] [Full Text] [Related]

  • 8. Papillary proliferation of the endometrium: a clinicopathologic study of 59 cases of simple and complex papillae without cytologic atypia.
    Ip PP, Irving JA, McCluggage WG, Clement PB, Young RH.
    Am J Surg Pathol; 2013 Feb; 37(2):167-77. PubMed ID: 23211295
    [Abstract] [Full Text] [Related]

  • 9. Clear cell carcinoma of the endometrium is characterized by a distinctive profile of p53, Ki-67, estrogen, and progesterone receptor expression.
    Lax SF, Pizer ES, Ronnett BM, Kurman RJ.
    Hum Pathol; 1998 Jun; 29(6):551-8. PubMed ID: 9635673
    [Abstract] [Full Text] [Related]

  • 10. Role of Morphometry and Matrix Metalloproteinase-9 Expression in Differentiating between Atypical Endometrial Hyperplasia and Low Grade Endometrial Adenocarcinoma.
    Assaf MI, Abd El-Aal W, Mohamed SS, Yassen NN, Mohamed EA.
    Asian Pac J Cancer Prev; 2018 Aug 24; 19(8):2291-2297. PubMed ID: 30139240
    [Abstract] [Full Text] [Related]

  • 11. Cervical stromal involvement by endometrial 'hyperplasia': a previously unreported phenomenon with recommendations to report as stage II endometrial carcinoma.
    Taylor J, McCluggage WG.
    Pathology; 2021 Aug 24; 53(5):568-573. PubMed ID: 34154843
    [Abstract] [Full Text] [Related]

  • 12. [Precursor lesions of endometrial carcinoma: diagnostic approach and molecular pathology].
    Lax S.
    Pathologe; 2011 Nov 24; 32 Suppl 2():255-64. PubMed ID: 22033684
    [Abstract] [Full Text] [Related]

  • 13. Expression, Epigenetic and Genetic Changes of HNF1B in Endometrial Lesions.
    Němejcová K, Tichá I, Kleiblová P, Bártů M, Cibula D, Jirsová K, Dundr P.
    Pathol Oncol Res; 2016 Jul 24; 22(3):523-30. PubMed ID: 26685938
    [Abstract] [Full Text] [Related]

  • 14. Immunolocalization of ERK1/2 and p-AKT in normal endometrium, endometrial hyperplasia, and early and advanced stage endometrioid endometrial adenocancer and their prognostic significance in malignant group.
    Gungorduk K, Ertas IE, Sahbaz A, Ozvural S, Sarica Y, Ozdemir A, Sayhan S, Gokcu M, Yilmaz B, Sanci M, Inan S, Harma M, Yildirim Y.
    Eur J Obstet Gynecol Reprod Biol; 2014 Aug 24; 179():147-52. PubMed ID: 24965996
    [Abstract] [Full Text] [Related]

  • 15. Immunohistochemical characterization of prototypical endometrial clear cell carcinoma--diagnostic utility of HNF-1β and oestrogen receptor.
    Hoang LN, Han G, McConechy M, Lau S, Chow C, Gilks CB, Huntsman DG, Köbel M, Lee CH.
    Histopathology; 2014 Mar 24; 64(4):585-96. PubMed ID: 24103020
    [Abstract] [Full Text] [Related]

  • 16. Molecular profiles of benign and (pre)malignant endometrial lesions.
    van der Putten LJM, van Hoof R, Tops BBJ, Snijders MPLM, van den Berg-van Erp SH, van der Wurff AAM, Bulten J, Pijnenborg JMA, Massuger LFAG.
    Carcinogenesis; 2017 Mar 01; 38(3):329-335. PubMed ID: 28203752
    [Abstract] [Full Text] [Related]

  • 17. Coordinate expression of Cdc25B and ER-alpha is frequent in low-grade endometrioid endometrial carcinoma but uncommon in high-grade endometrioid and nonendometrioid carcinomas.
    Wu W, Slomovitz BM, Celestino J, Chung L, Thornton A, Lu KH.
    Cancer Res; 2003 Oct 01; 63(19):6195-9. PubMed ID: 14559803
    [Abstract] [Full Text] [Related]

  • 18. Expression pattern of osteopontin in endometrial carcinoma: correlation with expression of the adhesion molecule CEACAM1.
    Briese J, Schulte HM, Bamberger CM, Löning T, Bamberger AM.
    Int J Gynecol Pathol; 2006 Apr 01; 25(2):161-9. PubMed ID: 16633066
    [Abstract] [Full Text] [Related]

  • 19. PINCH protein expression in normal endometrium, atypical endometrial hyperplasia and endometrioid endometrial carcinoma.
    Zhang HZ, Li XH, Zhang X, Zhang ZY, Meng YL, Xu SW, Zheng Y, Zhu ZL, Cui DS, Huang LX, Yan BY, Sun XF.
    Chemotherapy; 2010 Apr 01; 56(4):291-7. PubMed ID: 20714146
    [Abstract] [Full Text] [Related]

  • 20. IMMUNOHISTOCHEMISTRY IN ENDOMETRIAL HYPERPLASIA AND ENDOMETRIAL ADENOCARCINOMA.
    Socolov D, Socolov R, Lupascu IA, Rugina V, Gabia O, Garauleanu DM, Carauleanu A.
    Rev Med Chir Soc Med Nat Iasi; 2016 Apr 01; 120(2):355-62. PubMed ID: 27483717
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 31.